StonvexLoading…
StonvexStonvexStonvexCore line items from DVN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $16.79B | $15.92B | $15.14B | $19.83B |
Operating Income | $3.47B | $3.71B | $4.62B | $7.78B |
Net Income | $2.64B | $2.89B | $3.74B | $6.03B |
EPS (Diluted) | $4.17 | $4.56 | $5.84 | $9.12 |
Total Assets | $31.60B | $30.49B | $24.49B | $23.27B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.38B | $811.00M | $853.00M | $1.31B |
Free Cash Flow OCF − CapEx | $3.12B | $2.96B | $2.66B | $5.99B |
Shares Outstanding | 633.00M | 634.00M | 642.00M | 653.00M |